Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GITR agonistic stimulation enhances the anti-tumor immune response in a mouse model of ESCC. | Carcinogenesis | 2022 | 35880612 | PubTator, text mining | PubMed |
| RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation. | J Transl Med | 2022 | 35879796 | PubTator, text mining | PubMed |
| Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression. | Front Oncol | 2022 | 35875148 | PubTator, text mining | PubMed |
| Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses. | Front Cell Dev Biol | 2022 | 35874810 | PubTator, text mining | PubMed |
| Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting. | Front Immunol | 2022 | 35874729 | PubTator, text mining | PubMed |
| Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer. | Front Immunol | 2022 | 35874720 | PubTator, text mining | PubMed |
| Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells. | Front Immunol | 2022 | 35874714 | PubTator, text mining | PubMed |
| The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection. | Front Immunol | 2022 | 35874688 | PubTator, text mining | PubMed |
| The role of CD101-expressing CD4 T cells in HIV/SIV pathogenesis and persistence. | PLoS Pathog | 2022 | 35867722 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells in Cavernous Hemangioma. | Front Cell Dev Biol | 2022 | 35865633 | PubTator, text mining | PubMed |
| GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. | Dis Markers | 2022 | 35860689 | PubTator, text mining | PubMed |
| Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy. | Front Oncol | 2022 | 35860590 | PubTator, text mining | PubMed |
| Therapeutic targeting of regulatory T cells in cancer. | Trends Cancer | 2022 | 35853825 | PubTator, text mining | PubMed |
| RP11-552D4.1: a novel m6a-related LncRNA associated with immune status in glioblastoma. | Aging (Albany NY) | 2022 | 35852867 | PubTator, text mining | PubMed |
| Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35846134 | PubTator, text mining | PubMed |
| The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer. | Front Genet | 2022 | 35846130 | PubTator, text mining | PubMed |
| Multi-Omics Analysis and Machine Learning Prediction Model for Pregnancy Outcomes After Intracytoplasmic Sperm Injection-in vitro Fertilization. | Front Public Health | 2022 | 35844885 | PubTator, text mining | PubMed |
| Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner. | Front Immunol | 2022 | 35844577 | PubTator, text mining | PubMed |
| Antigenic Determinants of SARS-CoV-2-Specific CD4+ T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling. | Front Immunol | 2022 | 35844575 | PubTator, text mining | PubMed |
| SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. | Front Immunol | 2022 | 35844556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=55